XML 58 R33.htm IDEA: XBRL DOCUMENT
v3.19.3

Fair Value Measurements - Assets and Liabilities at Fair Value (Details) - USD ($) | 3 Months Ended |
--- | --- | ---
Sep. 30, 2019 | Mar. 31, 2018 | Dec. 31, 2018
Assets: |  |  |
Short-term investments | $ 874,383,000 |  | $ 601,217,000
Investment in Viking common stock | 41,542,000 |  | 46,191,000
Investment in warrants | 8,314,000 |  | 9,257,000
Total assets | 924,239,000 |  | 656,665,000
Liabilities: |  |  |
Amounts owed to former licensor | 61,000 |  | 199,000
Total liabilities | 9,850,000 |  | 12,741,000
Repayments of related party debt | 3,000,000.0 | $ 1,000,000.0 |
Transferred over Time | Phase 3 Clinical Trial |  |  |
Liabilities: |  |  |
Contract asset | 10,000,000 |  |
Maximum | Transferred over Time | Development, Regulatory, & Commercial Milestones and Tiered Royalties |  |  |
Liabilities: |  |  |
Investments | 375,000,000 |  |
Crystal |  |  |
Liabilities: |  |  |
Contingent liabilities | 1,826,000 |  | 6,477,000
CyDex |  |  |
Liabilities: |  |  |
Contingent liabilities | 465,000 |  | 514,000
Metabasis |  |  |
Liabilities: |  |  |
Contingent liabilities | 7,498,000 |  | 5,551,000
Level 1 |  |  |
Assets: |  |  |
Short-term investments | 2,171,000 |  | 1,326,000
Investment in Viking common stock | 41,542,000 |  | 46,191,000
Investment in warrants | 8,314,000 |  | 9,257,000
Total assets | 52,027,000 |  | 56,774,000
Liabilities: |  |  |
Amounts owed to former licensor | 61,000 |  | 199,000
Total liabilities | 61,000 |  | 199,000
Level 1 | Crystal |  |  |
Liabilities: |  |  |
Contingent liabilities | 0 |  | 0
Level 1 | CyDex |  |  |
Liabilities: |  |  |
Contingent liabilities | 0 |  | 0
Level 1 | Metabasis |  |  |
Liabilities: |  |  |
Contingent liabilities | 0 |  | 0
Level 2 |  |  |
Assets: |  |  |
Short-term investments | 872,147,000 |  | 599,891,000
Investment in Viking common stock | 0 |  | 0
Investment in warrants | 0 |  | 0
Total assets | 872,147,000 |  | 599,891,000
Liabilities: |  |  |
Amounts owed to former licensor | 0 |  | 0
Total liabilities | 7,498,000 |  | 5,551,000
Level 2 | Crystal |  |  |
Liabilities: |  |  |
Contingent liabilities | 0 |  | 0
Level 2 | CyDex |  |  |
Liabilities: |  |  |
Contingent liabilities | 0 |  | 0
Level 2 | Metabasis |  |  |
Liabilities: |  |  |
Contingent liabilities | 7,498,000 |  | 5,551,000
Level 3 |  |  |
Assets: |  |  |
Short-term investments | 65,000 |  | 0
Investment in Viking common stock | 0 |  | 0
Investment in warrants | 0 |  | 0
Total assets | 65,000 |  | 0
Liabilities: |  |  |
Amounts owed to former licensor | 0 |  | 0
Total liabilities | 2,291,000 |  | 6,991,000
Level 3 | Crystal |  |  |
Liabilities: |  |  |
Contingent liabilities | 1,826,000 |  | 6,477,000
Level 3 | CyDex |  |  |
Liabilities: |  |  |
Contingent liabilities | 465,000 |  | 514,000
Level 3 | Metabasis |  |  |
Liabilities: |  |  |
Contingent liabilities | $ 0 |  | $ 0

X
- Definition Contingent Liabilities, Fair Value Disclosure + References No definition available. + Details
Name: | lgnd_ContingentLiabilitiesFairValueDisclosure
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | lgnd_PaymentstoContingentValueRightHoldersandOtherContingencyPaymentsInvestingActivities
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Short-Term Investments, Fair Value Disclosure + References No definition available. + Details
Name: | lgnd_ShortTermInvestmentsFairValueDisclosure
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_AssetsFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_AssetsFairValueDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 8 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=118944033&loc=SL49130533-203044 + Details
Name: | us-gaap_ContractWithCustomerAssetGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 45 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740 + Details
Name: | us-gaap_EquitySecuritiesFvNi
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.1(h)) -URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910 + Details
Name: | us-gaap_Investments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of financial and nonfinancial obligations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_LiabilitiesFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_LiabilitiesFairValueDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_NotesReceivableFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of other liabilities. + References No definition available. + Details
Name: | us-gaap_OtherLiabilitiesFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |